-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS, INC. : CANACCORD GENUITY RAISES TARGET PRICE TO $13 FROM $10

Reuters·10/29/2026 13:12:40

Please log in to view news